Abstract
Background
Adiponectin is a fat-derived hormone produced and secreted exclusively by adipocytes that have anti-atherosclerotic effects. The aim of this study was to evaluate the relationship between fasting serum adiponectin levels and arterial stiffness among kidney transplant (KT) patients.
Methods
Fasting blood samples were obtained from 69 KT patients. Brachial–ankle pulse wave velocity (baPWV) was measured in the right or left brachial artery to the ankle segments using an automatic pulse wave analyzer. Plasma adiponectin levels were measured using a commercial enzyme-linked immunosorbent assay kit. Left or right baPWV values of >14.0 m/s were used to define the high arterial stiffness group.
Results
Thirty-five KT patients (35/69; 50.7 %) were defined in high arterial stiffness group. Diabetes (P = 0.013), smoking (P = 0.001), KT duration (P < 0.001), body weight (P = 0.013), waist circumference (P = 0.013), body mass index (P = 0.001), fasting glucose (P = 0.013), systolic blood pressure (P < 0.001), diastolic blood pressure (P = 0.008), and pulse pressure (P = 0.003) were higher, while serum adiponectin level (P = 0.004) was lower in high arterial stiffness group compared with low arterial stiffness group. Multivariate logistic regression analysis showed that adiponectin (odds ratio 0.90, 95 % confidence interval 0.81–0.99, P = 0.034) was still the independent predictors of arterial stiffness among the KT patients.
Conclusion
Serum fasting adiponectin level was inversely associated with arterial stiffness among KT patients.
Similar content being viewed by others
References
Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511–22.
Liefeldt L, Budde K. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transpl Int. 2010;23:1191–204.
Khoshdel AR, Carney SL. Arterial stiffness in kidney transplant recipients: an overview of methodology and applications. Urol J. 2008;5:3–14.
Verbeke F, Maréchal C, Van Laecke S, et al. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension. 2011;58:833–8.
Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J. 2010;74:24–33.
Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid–femoral and brachial–ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–7.
Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, et al. Prediction of cardiovascular events and all-cause mortality with brachial–ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60:556–62.
Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27:762–78.
Windham BG, Griswold ME, Farasat SM, et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens. 2010;23:501–7.
Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol. 2009;103:1411–6.
Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011;36:53–63.
Youn JC, Kim C, Park S, et al. Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol. 2013;163:316–9.
Lee MC, Lee CJ, Ho GJ, et al. Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients. Clin Transplant. 2010;24:E124–9.
Lee MC, Lee CJ, Ho GJ, et al. Fasting adiponectin correlates inversely with metabolic syndrome in kidney transplantation patients. Transplant Proc. 2011;43:2601–5.
Hsu BG, Ho GJ, Lee CJ, et al. Inverse association of serum long-acting natriuretic peptide and bone mass density in renal transplant recipients. Clin Transplant. 2012;26:E105–10.
Kubozono T, Miyata M, Ueyama K, et al. Acute and chronic effects of smoking on arterial stiffness. Circ J. 2011;75:698–702.
Kato A, Ishida J, Endo Y, et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2011;26:1967–76.
Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006;82:603–11.
Svensson M, Jardine A, Fellström B, et al. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012;17:393–400.
Strózecki P, Adamowicz A, Włodarczyk Z, et al. Factors associated with increased arterial stiffness in renal transplant recipients. Med Sci Monit. 2010;16:CR301–6.
Mitchell A, Opazo Saez A, Kos M, et al. Pulse wave velocity predicts mortality in renal transplant patients. Eur J Med Res. 2010;15:452–5.
Strozecki P, Adamowicz A, Kozlowski M, et al. Progressive arterial stiffening in kidney transplant recipients. Ann Transplant. 2011;16:30–5.
Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527–39.
Briet M, Boutouyrie P, Laurent S, et al. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82:388–400.
Opazo Saez A, Kos M, Witzke O, et al. Effect of new-onset diabetes mellitus on arterial stiffness in renal transplantation. Transpl Int. 2008;21:930–5.
Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–33.
Hirai T, Okuno A, Souda T, et al. Evaluation of arterial stiffness after successful renal transplantation using brachial–ankle pulse wave velocity. Transplant Proc. 2010;42:4061–3.
Lee M, Choh AC, Demerath EW, et al. Associations between trunk, leg and total body adiposity with arterial stiffness. Am J Hypertens. 2012;25:1131–7.
Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2012;302:H1231–40.
Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.
Ikonomidis I, Kadoglou N, Tsiotra PC, et al. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens. 2012;25:746–55.
de Faria AP, Demacq C, Figueiredo VN, et al. Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertens Res. 2013;36:1067–72.
El Khoudary SR, Barinas-Mitchell E, White J, et al. Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis. 2012;225:475–80.
Kato K, Matsuhisa M, Ichimaru N, et al. The impact of new-onset diabetes on arterial stiffness after renal transplantation. Endocr J. 2008;55:677–83.
Joannidès R, Monteil C, de Ligny BH, et al. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant. 2011;11:2414–22.
Gungor O, Kircelli F, Carrero JJ, et al. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients. Clin Nephrol. 2011;75:491–6.
Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18–33.
Vyssoulis GP, Karpanou EA, Kyvelou SM, et al. Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking. J Clin Hypertens. 2008;10:201–7.
Koumaras C, Tziomalos K, Stavrinou E, et al. Effects of renin–angiotensin–aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens. 2014;8:74–82.
Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16:1091–8.
Iwashima Y, Horio T, Kumada M, et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006;98:1603–8.
Nishimura M, Hashimoto T, Kobayashi H, et al. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients. Nephrol Dial Transplant. 2006;21:1640–7.
Abdallah E, Waked E, Nabil M, et al. Adiponectin and cardiovascular outcomes among hemodialysis patients. Kidney Blood Press Res. 2012;35:247–53.
Roos M, Baumann M, Liu D, et al. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study. Regul Pept. 2012;178:11–5.
Cañas L, Bayés B, Granada ML, et al. Is adiponectin a marker of preclinical atherosclerosis in kidney transplantation? Clin Transplant. 2012;26:259–66.
Menon V, Li L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2599–606.
Ohashi N, Kato A, Misaki T, et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med. 2008;47:485–91.
Alam A, Molnar MZ, Czira ME, et al. Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8:460–7.
Sattar N, Wannamethee G, Sarwar N, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006;114:623–9.
Hao G, Li W, Guo R, et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis. 2013;228:29–35.
Kanhai DA, Kranendonk ME, Uiterwaal CS, et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev. 2013;14:555–67.
SookLee E, Park SS, Kim E, et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epodemiol. 2013;42:1029–39.
Wu Z, Cheng Y, Aung LH, et al. Association between adiponectin concentrations and cardiovascular disease in diabetic patients: a systematic review and meta-analysis. PLoS ONE. 2013;8:e78485.
Wu ZJ, Cheng YJ, Gu WJ, et al. Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis. Metabolism. 2014 (in press).
Nanayakkara PW, Le Poole CY, Fouque D, et al. Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3–5 chronic kidney disease. Clin Nephrol. 2009;72:21–30.
Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–41.
Acknowledgments
This study was supported by a grant from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD101-06).
Conflict of interest
All the authors have declared that there are no conflicts of interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. J. Ho and M. C. Lee contributed equally to this study.
About this article
Cite this article
Ho, GJ., Lee, MC., Lee, CJ. et al. Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol 19, 534–541 (2015). https://doi.org/10.1007/s10157-014-1010-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-014-1010-1